Propofol,remifentanilo,viadil Fis(rx11,2204004001
reposicion stock
15 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4967-2653-SE14 | 12-09-2014 | Fresenius Kabi Chile Limitada | $761.600 |
| 4967-1443-SE14 | 03-06-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $261.800 |
| 4967-660-SE14 | 10-03-2014 | Megalabs Chile S.A. | $624.750 |
| 4967-467-SE14 | 18-02-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $261.800 |
| 4967-464-SE14 | 18-02-2014 | Megalabs Chile S.A. | $624.750 |
| 4967-332-SE14 | 13-02-2014 | Industrial y Comercial Baxter de Chile Limitada | $202.348 |
| 4967-334-SE14 | 13-02-2014 | Industrial y Comercial Baxter de Chile Limitada | $202.348 |
| 4967-3709-SE13 | 31-12-2013 | B Braun Medical SpA | $89.250 |
| 4967-3711-SE13 | 31-12-2013 | Fresenius Kabi Chile Limitada | $761.600 |
| 4967-3663-SE13 | 26-12-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-3440-SE13 | 06-12-2013 | Fresenius Kabi Chile Limitada | $380.800 |
| 4967-3345-SE13 | 25-11-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-3205-SE13 | 11-11-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-3062-SE13 | 25-10-2013 | B Braun Medical SpA | $89.250 |
| 4967-3063-SE13 | 25-10-2013 | Fresenius Kabi Chile Limitada | $380.800 |
| 4967-2910-SE13 | 08-10-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-2696-SE13 | 11-09-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $326.060 |
| 4967-2596-SE13 | 07-09-2013 | B Braun Medical SpA | $89.250 |
| 4967-2597-SE13 | 07-09-2013 | Fresenius Kabi Chile Limitada | $571.200 |
| 4967-2560-SE13 | 02-09-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-2389-SE13 | 13-08-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-2356-SE13 | 08-08-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $326.060 |
| 4967-2028-SE13 | 09-07-2013 | Fresenius Kabi Chile Limitada | $571.200 |
| 4967-1667-SE13 | 04-06-2013 | Fresenius Kabi Chile Limitada | $571.200 |
| 4967-1668-SE13 | 04-06-2013 | B Braun Medical SpA | $89.250 |
| 4967-1463-SE13 | 14-05-2013 | Fresenius Kabi Chile Limitada | $571.200 |
| 4967-758-SE13 | 04-03-2013 | B Braun Medical SpA | $89.250 |
| 4967-739-SE13 | 01-03-2013 | Industrial y Comercial Baxter de Chile Limitada | $168.623 |
| 4967-378-SE13 | 30-01-2013 | B Braun Medical SpA | $89.250 |
| 4967-375-SE13 | 30-01-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $326.060 |
| 4967-379-SE13 | 30-01-2013 | Industrial y Comercial Baxter de Chile Limitada | $337.246 |
| 4967-376-SE13 | 30-01-2013 | Megalabs Chile S.A. | $624.750 |
| 4967-377-SE13 | 30-01-2013 | Fresenius Kabi Chile Limitada | $571.200 |
Fuente original:ficha mercadopublico.cl
